Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Tetramethylrhodamine isothiocyanate Isomer R (AC209)
Cat.#: ASSD-209
Specifications
Description Tetramethylrhodamine isothiocyanate Isomer R is an amine-reactive fluorescent probe useful in the fluorescent labeling of proteins or peptides. Also widely used in the labelling of proteins. Synonyms 6-TRITC, R-isomer Size 5 mg, 10 mg Applications An amine reactive fluorescent label Molecule Weight 443.52 Molecular formula C25H21N3O3S CAS Number 80724-20-5 MDL Number MFCD00063517 Solubility soluble in 1M NH4OH in MeOH Form Powder Storage Store at 4° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-223 Antifade Fluorescence Mounting Medium (aqueous) (AC223) 10 mL inquiry ASSD-171 Ionomycin calcium salt (AC171) 1mg, 5mg inquiry ASSD-106 Hoechst 33342 Staining Solution (10mg/ml) (AC106) 5 mL, 10 mL inquiry ASSD-158 Eosin Y (AC158) 1g inquiry ASSD-200 Ethylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[3-difluoromethyl-4-phosphoanilinamidosuccinic Acid] Diamide (AC200) 500 μg inquiry ASSD-115 7-Amino-4-methylcoumarin (AC115) 100 mg, 500 mg, 1 g inquiry ASSD-216 K 114 (AC216) 10 mg, 50 mg inquiry ASSD-206 Eosine-5-isothiocyanate (AC206) 50 mg inquiry ASSD-226 Antifade Fluorescence Mounting Medium (hard set) (AC226) 10 mL inquiry ASSD-136 LUF7445/A2A antagonist (AC136) 50 μg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket